Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Martel

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' replyK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevirK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Journal of Clinical Microbiology|December 11, 2020
Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical LaboratoriesC Therrien, B Serhir, M Bélanger-Collard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2015
Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell CountsWei Cao, Vikram Mehraj, Benoit Trottier, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' replyK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevirK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Journal of Clinical Microbiology|December 11, 2020
Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical LaboratoriesC Therrien, B Serhir, M Bélanger-Collard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2015
Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell CountsWei Cao, Vikram Mehraj, Benoit Trottier, et al.
Pageof 3